Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. MONRY
2. NYXH
3. PNR
4. ONON
5. IAUX
6. KKR
7. LLY
8. DAVA
9. MONC:IM
10. BRKCF

Go back to Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 244.32 --0 (-0%)
Previous Close $244.32    52 Week High $109.10 
Open $244.32    52 Week Low $31.38 
Day High $244.32    P/E N/A 
Day Low $244.32    EPS $-1.45 
Volume 363       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.62 --0 (-0%)
Previous Close $14.62    52 Week High $5.58 
Open $14.62    52 Week Low $3.60 
Day High $14.62    P/E N/A 
Day Low $14.62    EPS $0.00 
Volume 34,686       

SANOFI (NASDAQ: SNY) Delayed: 42.50 --0 (-0%)
Previous Close $42.50    52 Week High $44.76 
Open $42.50    52 Week Low $36.81 
Day High $42.50    P/E N/A 
Day Low $42.50    EPS $0.00 
Volume 4,798